International Journal of Clinical Research

Objective To explore the effect of acetyl cysteine combined with budesonide atomization in the treatment of elderly patients with COPD based on the anti-aging effect. Methods A total of 60 patients participated in this study. The study started from January 2024 and ended from December 2024. They were divided into two groups, control group and experimental group, with 30 patients in each group. The experimental group was treated with acetylcysteine on the basis of the control group, and the blood oxygen index, inflammatory factors, adverse reactions and quality of life of the two groups were analyzed. Results After the two groups of patients were provided with different intervention measures, the blood oxygen index of the experimental group was better than that of the control group, p<0.05, the level of inflammatory factors of the patients was assessed, the level of inflammatory factors of the experimental group was significantly better, p<0.05, the adverse reactions of the patients were compared, the adverse reactions of the experimental group were lower than that of the control group, p<0.05, the quality of life of the patients was compared. The experimental group was superior to the control group (p<0.05). Conclusion Providing acetyl cysteine and budesonide atomization therapy for elderly COPD patients can improve the blood oxygen index, stabilize the level of inflammatory factors in patients, and reduce the occurrence of adverse reactions, which is worth advocating.

Anti-aging effect; Acetylcysteine; Budesonide; Atomization therapy; Senile COPD